BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 2,380.00
-40.00 (-1.65%)
At close: Jun 29, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 11.58 billion as of June 29, 2026. Its market cap has decreased by -58.39% in one year.
Market Cap
11.58B
Enterprise Value
15.99B
Revenue
23.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,380.00
Market Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 11.58B, a decrease of -91.79%. That is a compound annual growth rate of -52.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 11.58B | -49.68% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 286.96B |
| DreamCIS | 76.26B |
| P&K Skin Research Center | 47.08B |
| HLB bioStep | 43.21B |
| WOOJUNG BIO | 38.71B |
| C&R Research | 31.61B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 18.54B |